KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vir Biotechnology (VIR) Depreciation & Amortization (CF) (2018 - 2025)

Vir Biotechnology's Depreciation & Amortization (CF) history spans 8 years, with the latest figure at $2.9 million for Q4 2025.

  • On a quarterly basis, Depreciation & Amortization (CF) changed 0.42% to $2.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $11.7 million, a 19.77% decrease, with the full-year FY2025 number at $11.7 million, down 19.77% from a year prior.
  • Depreciation & Amortization (CF) hit $2.9 million in Q4 2025 for Vir Biotechnology, down from $3.0 million in the prior quarter.
  • Over the last five years, Depreciation & Amortization (CF) for VIR hit a ceiling of $5.6 million in Q1 2023 and a floor of $1.3 million in Q1 2021.
  • Historically, Depreciation & Amortization (CF) has averaged $2.9 million across 5 years, with a median of $2.9 million in 2024.
  • Biggest five-year swings in Depreciation & Amortization (CF): surged 297.32% in 2023 and later plummeted 36.53% in 2025.
  • Tracing VIR's Depreciation & Amortization (CF) over 5 years: stood at $1.4 million in 2021, then soared by 70.68% to $2.4 million in 2022, then soared by 90.43% to $4.5 million in 2023, then plummeted by 35.57% to $2.9 million in 2024, then increased by 0.42% to $2.9 million in 2025.
  • Business Quant data shows Depreciation & Amortization (CF) for VIR at $2.9 million in Q4 2025, $3.0 million in Q3 2025, and $2.9 million in Q2 2025.